Provided by Tiger Trade Technology Pte. Ltd.

Aktis Oncology

18.90
+0.49002.66%
Post-market: 18.50-0.4000-2.12%18:42 EST
Volume:249.29K
Turnover:4.69M
Market Cap:992.67M
PE:- -
High:19.50
Open:18.22
Low:17.90
Close:18.41
52wk High:29.16
52wk Low:16.80
Shares:52.52M
Float Shares:17.65M
Volume Ratio:1.72
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-62.4570
ROE:-26.50%
ROA:-14.80%
PB:-7.50
PE(LYR):-0.30

Loading ...

BUZZ-J.P. Morgan initiates coverage of Aktis Oncology with 'overweight' rating

Reuters
·
Feb 04

BofA Securities Initiates Coverage on Aktis Oncology With Buy Rating, $34 Price Target

MT Newswires Live
·
Feb 03

Aktis Oncology Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $34

THOMSON REUTERS
·
Feb 03

Wall Street's Top Analysts Issue Latest Ratings: Adobe Downgraded, Palantir Upgraded

Deep News
·
Feb 03

Aktis Oncology Initiated at Overweight by JP Morgan

Dow Jones
·
Feb 03

TD Cowen Initiates Aktis Oncology at Buy

MT Newswires Live
·
Feb 03

Leerink Partners Initiates Aktis Oncology at Outperform With $31 Price Target

MT Newswires Live
·
Feb 03

Aktis Oncology Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $31

THOMSON REUTERS
·
Feb 03

Aktis Oncology initiated with a Buy at TD Cowen

TIPRANKS
·
Feb 03

Aktis Oncology Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Feb 03

Aktis Oncology initiated with an Overweight at JPMorgan

TIPRANKS
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

Aktis Oncology Inc : JP Morgan Initiates Coverage With Overweight Rating; Target Price $30

THOMSON REUTERS
·
Feb 03

Merck veteran Perlmutter-led Eikon ‍Therapeutics eyes $908 million valuation in IPO

Reuters
·
Jan 28

Aktis Oncology Files Initial Beneficial Ownership Statement Listing Eli Lilly as 10% Owner

Reuters
·
Jan 15

Insiders Make Bold Move as Key Players Double Down on Aktis Oncology

TIPRANKS
·
Jan 15

MPM BioVentures 2018, L.P. Reports Acquisition of Common Shares in Aktis Oncology Inc

Reuters
·
Jan 15

10% Owner Ansbert Gadicke Reports Acquisition of Aktis Oncology Inc. Common Shares

Reuters
·
Jan 15

Helen Kim Reports 10.9% Stake in Aktis Oncology Inc as of Jan 12, 2026 - SEC Filing

THOMSON REUTERS
·
Jan 15

Assessing Aktis Oncology (AKTS) Valuation After Recent Share Price Movement And Ongoing Losses

Simply Wall St.
·
Jan 14